Because of its D-amino acid configuration and reversed sequence, it is more stable in vivo and resists enzymatic degradation
But it gives a baseline idea of how different applications align with certain C-ratings
Although the FDA has yet to approve BPC 157 for medical use, the growing body of anecdotal evidence and clinical reports suggests that these peptides hold promise in a variety of treatments
You might be wondering, "How would I even know if it degraded?" It's a great question
This effect can be explained by three mechanisms: First, the ability of PA to chelate iron, as Tinkov et al
The ex vivo fluorescence imaging of organs and the tumor taken from 5 h post-injection similarly showed that the intensity of the fluorescence signal of the tumor was more than ten times higher than that of other organs, such as the liver and kidney (Fig